Toronto Dominion Bank acquired a new position in shares of monday.com Ltd. (NASDAQ:MNDY – Free Report) during the second quarter, according to the company in its most recent disclosure with the SEC. The firm acquired 500 shares of the company’s stock, valued at approximately $120,000.
A number of other institutional investors have also recently modified their holdings of MNDY. Mercer Global Advisors Inc. ADV increased its position in shares of monday.com by 4.4% during the second quarter. Mercer Global Advisors Inc. ADV now owns 1,124 shares of the company’s stock worth $271,000 after purchasing an additional 47 shares in the last quarter. Crossmark Global Holdings Inc. lifted its position in monday.com by 4.0% in the second quarter. Crossmark Global Holdings Inc. now owns 1,303 shares of the company’s stock valued at $314,000 after buying an additional 50 shares during the last quarter. FDx Advisors Inc. boosted its position in shares of monday.com by 4.7% during the 2nd quarter. FDx Advisors Inc. now owns 2,000 shares of the company’s stock worth $482,000 after purchasing an additional 90 shares during the period. Oppenheimer Asset Management Inc. boosted its position in shares of monday.com by 4.6% during the second quarter. Oppenheimer Asset Management Inc. now owns 2,065 shares of the company’s stock worth $497,000 after buying an additional 91 shares during the period. Finally, American International Group Inc. grew its position in monday.com by 2.3% in the 1st quarter. American International Group Inc. now owns 4,550 shares of the company’s stock valued at $1,028,000 after acquiring an additional 102 shares in the last quarter. 73.70% of the stock is currently owned by institutional investors and hedge funds.
monday.com Stock Down 3.1 %
NASDAQ:MNDY opened at $269.14 on Wednesday. The stock’s 50-day simple moving average is $251.96 and its 200 day simple moving average is $229.91. The firm has a market capitalization of $12.99 billion, a PE ratio of 708.26, a price-to-earnings-growth ratio of 13.58 and a beta of 1.32. monday.com Ltd. has a twelve month low of $122.13 and a twelve month high of $285.64.
Wall Street Analyst Weigh In
A number of research analysts recently issued reports on the company. William Blair reiterated an “outperform” rating on shares of monday.com in a report on Monday, June 24th. TD Cowen raised their price objective on monday.com from $300.00 to $320.00 and gave the stock a “buy” rating in a report on Thursday, September 26th. JPMorgan Chase & Co. upped their price target on shares of monday.com from $270.00 to $300.00 and gave the company an “overweight” rating in a research report on Tuesday, August 13th. Citigroup lifted their target price on monday.com from $296.00 to $327.00 and gave the company a “neutral” rating in a research note on Wednesday, September 25th. Finally, Bank of America increased their price target on shares of monday.com from $280.00 to $300.00 and gave the stock a “buy” rating in a report on Tuesday, August 13th. Five equities research analysts have rated the stock with a hold rating and sixteen have issued a buy rating to the company. According to MarketBeat, monday.com presently has a consensus rating of “Moderate Buy” and an average target price of $296.16.
Read Our Latest Analysis on monday.com
monday.com Profile
monday.com Ltd., together with its subsidiaries, develops software applications in the United States, Europe, the Middle East, Africa, the United Kingdom, and internationally. The company provides Work OS, a cloud-based visual work operating system that consists of modular building blocks used and assembled to create software applications and work management tools.
Featured Articles
- Five stocks we like better than monday.com
- What is Insider Trading? What You Can Learn from Insider Trading
- Why Lennar Stock Could Be the Best Play in the Housing Market
- Quiet Period Expirations Explained
- 2 Energy Stocks Fueling the AI Datacenter Boom
- Technology Stocks Explained: Here’s What to Know About Tech
- Will Marinus Pharmaceuticals Be the Next Big Winner in Biotech?
Receive News & Ratings for monday.com Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for monday.com and related companies with MarketBeat.com's FREE daily email newsletter.